Clinical trial
A Randomized, Observer-blind, Active Comparator-controlled, Multicenter, Phase 3 Study to Assess the Efficacy, Safety, and Immunogenicity of a Plant-derived Quadrivalent VLP Influenza Vaccine in Adults 65 Years of Age and Older
NCT03739112 is registered in ClinicalTrials.gov with Medicago as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized, Observer-blind, Active Comparator-controlled, Multicenter, Phase 3 Study to Assess the Efficacy, Safety, and Immunogenicity of a Plant-derived Quadrivalent VLP Influenza Vaccine in Adults 65 Years of Age and Older
- Lead sponsor
- Medicago
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- September 18, 2018
- Completion date
- July 16, 2019
- Enrollment
- 12,794 (actual)
- Sites
- 104
Conditions
As the registry lists them; a condition with its own page is linked.